Class IOngoingD-0511-2024
Drug recall · June 5, 2024
Tirzepatide 10 mg/0.5 mL Sterile Solution recall
Why: Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
- Lots / codes
Lot #: 748127, Exp 9/24/2024
- Quantity
- 751 vials
- Company
- Revive Rx LLC dba Revive Rx Pharmacy, Houston, TX
- Distribution
- USA Nationwide
- Initiated
- April 20, 2024 · Voluntary: Firm initiated
- Classified
- May 29, 2024
- Reported
- June 5, 2024
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.